Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 655 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study... January 7, 2020 Growing the Cancer Research Pipeline by Expanding Opportunities August 29, 2024 ΟΡΘΟΚΟΛΙΚΟΣ ΚΑΡΚΙΝΟΣ February 7, 2019 Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer June 4, 2020 Load more HOT NEWS Scientists Link a Single Type of Bacteria to Colorectal Cancer Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer Food for Thought: A Fresh Perspective on Nutrition Regional Node Radiotherapy Significantly Reduced Breast Cancer Mortality and All-Cause Mortality...
